Founded in 1980, Noble Fund Managers was a London, England based venture capital and investment management firm and subsidiary of the Noble Group.
The firm was dedicated to middle and small capital companies. For these companies, Noble Fund Managers offered financial advisory services with research, sales and sales trading services. They worked with companies whose valuation were between £2 million and £250 million and managed six investment funds between £10 million and £100 million.
In February, 2010 Noble Fund Managers was acquired by Amati Global Partners.
Noble Fund Managers invested in Staccato Communications, Ipanema Technologies, Garlik, Ad.IQ, Population Genetics Technologies, Optasia Medical, InforSense and Txt4.
They exited investments in Ipanema Technologies, InforSense, Garlik and Intense.
Population Genetics Technologies Limited is a company that develops the identification of genetic variant technology.